As of January 2025, Medigen Vaccine Biologics Corporation has a market cap of $362.51M. This makes Medigen Vaccine Biologics Corporation the world's 13165th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $620.59M | -11.84% |
2023 | $703.93M | 0.86% |
2022 | $697.91M | -76.76% |
2021 | $3.00B | 190.29% |
2020 | $1.03B | 261.40% |
2019 | $286.19M | -17.88% |
2018 | $348.51M | 29.25% |
2017 | $269.65M | -10.79% |
2016 | $302.25M | -5.36% |
2015 | $319.37M | - |